Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Companies / L••••• M•••••• I•••

L••••• M•••••• I•••

Stage unknownGlen Allen, VABiotechnology
Facts
Year of incorporation
2021sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
2
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
0
Financing history
2 rounds
  1. Dec 23, 2024
    Form D equity offering · $1.1M (form d sold) · 15 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “L••••• M•••••• I••• filed Form D: $1,058,000 sold of $1,500,000, Biotechnology”
  2. Dec 11, 2023
    Form D equity offering · $615,000 (form d sold) · 13 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “L••••• M•••••• I••• filed Form D: $615,000 sold of $800,000, Biotechnology”
Investors on record
0 edges
No named investor yet.
People
2 officers, 2 directors
Timeline
2
  1. May 28, 2025
    L••••• M•••••• I••• filed Form D: $615,000 sold of $800,000, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. May 28, 2025
    L••••• M•••••• I••• filed Form D: $1,058,000 sold of $1,500,000, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
19 observations
Every observation on this company